Synthesis and evaluation of naphthalene derivatives as potent STAT3 inhibitors and agents against triple-negative breast cancer growth and metastasis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Synthesis and evaluation of naphthalene derivatives as potent STAT3 inhibitors and agents against triple-negative breast cancer growth and metastasis

Published:2022-11-12 Issue:2 Volume:197 Page:255-267
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Yang Zhengyan,Xu Hongyun,Yang Yupo,Duan Chaoqun,Zhang Pai,Wang Yang,Fu Kai,Shen Yonghong,Xu Marvin Xuejun^ORCID

Funder

High-end Foreign Experts Recruitment Plan of China

Science and Technology Plan Project of Kaifeng

Young Scientists Fund

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s10549-022-06790-2.pdf

Reference38 articles.

1. Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin 71(3):209–249. https://doi.org/10.3322/caac.21660

2. Kumar P, Aggarwal R (2016) An overview of triple-negative breast cancer[J]. Arch Gynecol Obstet 293(2):247–269. https://doi.org/10.1007/s00404-015-3859-y

3. Jhan JR, Andrechek ER (2017) Triple-negative breast cancer and the potential for targeted therapy[J]. Pharmacogenomics 18(17):1595–1609. https://doi.org/10.2217/pgs-2017-0117

4. Yu H, Pardoll D, Jove R (2009) STATs in cancer inflammation and immunity: a leading role for STAT3[J]. Nat Rev Cancer 9(11):798–809. https://doi.org/10.1038/nrc2734

5. Darnell JJ, Kerr IM, Stark GR (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins[J]. Science 264(5164):1415–1421. https://doi.org/10.1126/science.8197455

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small molecular inhibitors and degraders targeting STAT3 for cancer therapy: An updated review (from 2022 to 2024);Chinese Chemical Letters;2024-09

2. Interleukin-6 serves as a critical factor in various cancer progression and therapy;Medical Oncology;2024-06-20

3. Potential therapeutic targets of the JAK2/STAT3 signaling pathway in triple-negative breast cancer;Frontiers in Oncology;2024-04-18

4. Selective Construction of C–S/S–N Bonds from N-Substituted O-Thiocarbamates and Indoles under Transition-Metal-Free Conditions;The Journal of Organic Chemistry;2024-02-29

5. Targeting JAK2/STAT3 for the treatment of cancer: A review on recent advancements in molecular development using structural analysis and SAR investigations;Bioorganic Chemistry;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3